Barclays’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $43K | Sell |
|
|||||
|
2025
Q2 | $30K | Sell |
|
|||||
|
2025
Q1 | $67K | Sell |
|
|||||
|
2024
Q4 | $180K | Buy |
|
|||||
|
2024
Q3 | $304K | Buy |
|
|||||
|
2024
Q2 | $66K | Sell |
|
|||||
|
2024
Q1 | $155K | Sell |
|
|||||
|
2023
Q4 | $195K | Buy |
|
|||||
|
2023
Q3 | $42K | Buy |
|
|||||
|
2023
Q2 | $86K | Sell |
|
|||||
|
2023
Q1 | $103K | Buy |
|
|||||
|
2022
Q4 | $42K | Buy |
|
|||||
|
2022
Q3 | $8K | Sell |
|
|||||
|
2022
Q2 | $140K | Sell |
|
|||||
|
2022
Q1 | $175K | Sell |
|
|||||
|
2021
Q4 | $335K | Buy |
|
|||||
|
2021
Q3 | $134K | Buy |
|
|||||
|
2021
Q2 | $60K | Sell |
|
|||||
|
2021
Q1 | $244K | Buy |
|
|||||
|
2020
Q4 | $46K | Sell |
|
|||||
|
2020
Q3 | $27K | Sell |
|
|||||
|
2020
Q2 | $287K | Buy |
|
|||||
|
2020
Q1 | $138K | Buy |
|
|||||
|
2019
Q4 | $241K | Buy |
|
|||||
|
2019
Q3 | $75K | Sell |
|
|||||
|
2019
Q2 | $170K | Buy |
|
|||||
|
2019
Q1 | $89K | Buy |
|
|||||
|
2018
Q4 | $18K | Sell |
|
|||||
|
2018
Q3 | $241K | Buy |
|
|||||
|
2018
Q2 | $38K | Sell |
|
|||||
|
2018
Q1 | $163K | Sell |
|
|||||
|
2017
Q4 | $575K | Buy |
|
|||||
|
2017
Q3 | $471K | Buy |
|
|||||
|
2017
Q2 | $498K | Buy |
|
|||||
|
2017
Q1 | $183K | Sell |
|
|||||
|
2016
Q4 | $426K | Buy |
|
|||||
|
2016
Q3 | $64K | Sell |
|
|||||
|
2016
Q2 | $907K | Buy |
|
|||||
|
2016
Q1 | $34K | Sell |
|
|||||
|
2015
Q4 | $468K | Buy |
|
|||||
|
2015
Q3 | $300K | Buy |
|
|||||
|
2015
Q2 | $6K | Sell |
|
|||||
|
2015
Q1 | $0 | Sell |
|
|||||
|
2014
Q4 | $0 | Sell |
|
|||||
|
2014
Q3 | $63K | Sell |
|
|||||
|
2014
Q2 | $125K | Buy |
|
|||||
|
2014
Q1 | $77K | Buy |
|
|||||
|
2013
Q4 | $16K | Sell |
|
|||||
|
2013
Q3 | $36K | Sell |
|
|||||
|
2013
Q2 | $41K | Buy |
|